Pathobiology of Inflammation to Cell Death  by Rock, Kenneth L.
From the
Medic
Financial d
Correspon
of Pa
Worc
1083-8791
doi:10.101Pathobiology of Inflammation to Cell Death
Kenneth L. RockWhen a cell dies in vivo, the innate immune system
investigates the scene of the crime. If the death of the
cell is physiological (eg, occurring as part of normal
cell turnover), then the corpse is cleared, and little
else is done. In fact, as part of this process, phagocytes
that ingest normal apoptotic cells can actively suppress
tissue responses by elaborating anti-inflammatory
cytokines [1]. But if the cell has died unexpectedly
from some pathological process, then the innate
immune system expands its investigation.
The earliest response to abnormal cell death is an
acute inflammatory response. In this process, dead cells
stimulate the production of proinflammatory media-
tors by the monocytes/macrophages that result in
increased blood flow, leakage of protein-rich fluid
from venules, and recruitment of neutrophils, followed
by monocytes to the site of damage [2]. The recruited
leukocytes attempt to clear the corpses and stimulate
tissue repair. This process resolves once the stimulus
(ie, cell death and/or associated factors) driving these
events is removed and the damage is repaired. Recently,
interleukin (IL)-1was shown to be a keymediator in the
recruitment of neutrophils [3]. Other innate mecha-
nisms that sense abnormal cell death and the mediators
that orchestrate the inflammatory response in this
setting remain poorly understood, however.
In parallel to the inflammatory process, the innate
immune system also may mobilize the adaptive
immune system to respond to antigens associated
with dying cells. As part of this process, dendritic cells
internalize antigens from dead cells and present them
as peptides bound to major histocompatibility class
(MHC) class I and MHC class II molecules [4]. In
addition, dead cells can stimulate dendritic cells to mi-
grate to secondary lymphoid tissue and mature into an
immunostimulatory state [5]. Through these mecha-
nisms, dendritic cells alert T cells to potential patho-
logical situations in the peripheral tissues that areDepartment of Pathology, University of Massachusetts
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antigenic peptides presented on the MHC molecules
of the mature and stimulatory dendritic cells, then an
adaptive immune response is initiated.
Why are the innate and adaptive immune systems
so concerned with cell death? The current notion is
that if cells are dying under nonphysiological condi-
tions, then there is an underlying pathological process,
and this is potentially dangerous to the host. According
to this idea, the innate immune system has evolved
mechanisms to detect this potential danger [6,7].
When death is detected, the ensuing acute inflamma-
tory response rapidly delivers the soluble and cellular
defenses that attempt to neutralize or ‘‘wall off’’ the
injurious process and ultimately repair the damage.
Similarly, cell death alerts the adaptive immune system
to a potential problem in ways that will mobilize this
arm of the immune system if immunogenic antigens
are present.
These immune responses are double-edged
swords. On the one hand, they rapidly mobilize host
defense to the potential problem before it gets out of
control, but on the other hand, the acute inflammatory
response is indiscriminant and can damage normal
tissue [7]. Although this may be a small price to pay
for containing an injurious process, there are many
settings in which the recruited response is of no benefit
(eg, in a sterile ischemic infarct there is nothing to
defend against) and actually may make the situation
worse. In fact, the cell death–induced inflammatory re-
sponse is thought to contribute to the pathogenesis of
various diseases. Similarly, in individuals so predis-
posed, dead cells may help stimulate an adaptive
response to autologous antigens and contribute to the
development of autoimmunity. Given these ‘‘costs’’
and ‘‘benefits,’’ the innate immune response to dying
cells is medically important.
Precisely how the innate system recognizes cell
death and discriminates between normal physiological
and pathological cell death is not fully understood.
Apoptotic cells express ‘‘eat me’’ signals, like phospha-
tidyl serine on the outer leaflet of the plasma mem-
brane, that cause phagocytes to ingest these cells and
produce anti-inflammatory mediators, such as trans-
forming growth factor b and interleukin (IL)-10 [1].
In contrast, necrotic cells typically provoke inflamma-
tory responses (and adaptive ones if antigens are137
138 Biol Blood Marrow Transplant 15:137-138, 2009K. Rockpresent). Therefore, one factor that influences the host
response is the mechanism of cell death. In some situa-
tions, however, apoptotic cells also stimulate inflam-
mation and promote the generation ofT cell responses.
In some cases (eg, infections where cytopathic
microbes are causing cell death), responses to dying cells
are stimulated inpartby theunderlyingpathological pro-
cess. In such a situation, pattern recognition receptors,
such as Toll-like receptors (TLR) on leukocytes, can
recognize microbial molecules and stimulate inflamma-
tion and adaptive immune responses [8]; however, cell
death (eg, in sterile situations) itself is sufficient to trigger
these responses [7]. This is thought to be because the in-
nate immune system has evolved mechanisms to detect
the exposure or release of intracellular molecules that
normally are hidden from view in living cells [9]. Thus,
the release of these intracellular molecules is a sign of
cell damage and potential danger. These immunostimu-
latorymolecules are collectively referred to asdanger sig-
nals, ordamage-associatedmolecularpatterns (DAMPs).
The number of different kinds of DAMPs in cells is
unknown. Thus far, several putative DAMPs have
been identified. These molecules include uric acid,
high-mobility group box 1 (HMGB1) protein, non-
muscle myosin heavy chains, heat shock proteins, and
some other molecules. Moreover, more DAMPs al-
most certainly remain to be discovered [9]. Some
DAMPs may stimulate leukocytes directly, whereas
others may work by generating mediators from extra-
cellular components by cleaving extracellular matrix
proteins or activating complement. There also is rela-
tively limited information regarding which receptors
sense the release of DAMPs and stimulate the immune
responses. There is evidence that TLR-2 and -4 sense
cell death and in particular HMGB1, but these mole-
cules appear to play a relatively minor role in trigger-
ing the inflammatory response to dying cells [3].
There also is evidence that the intracellular pattern
recognition receptor NLRP3 (NALP3, cyropyrin), is
involved in the generation of IL-1b and inflammatory
responses to the DAMP uric acid [10], but its role in
the response to dying cells remains unknown.Ultimately, to gainmore insight into the inflamma-
tory response to cell death, it will be necessary to iden-
tify the various DAMPs that trigger this process and
elucidate the pathways that they stimulate. This is
crucial to understanding the biology of these responses
and how they contribute to health and disease. More-
over, because cell death–induced immune responses
contribute to disease pathogenesis, these pathways
are potential molecular targets for therapeutics to
modulate the cell death–induced immune responses.ACKNOWLEDGMENTS
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